TransMedics logo
TransMedics
TMDX | NASDAQ
Chart Builder DCF Calculator
$92.21
+$0.83 (+0.91%)
At close: Nov 16, 2026, 4:00 PM ET
$91.55
-$0.66 (-0.72%)
After-hours: Nov 16, 2026, 7:41 PM ET

TransMedics Company Profile

Company profile explained

Company Profile

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.

Key Executives

Name Position
Waleed H. Hassanein Founder, President, Chief Executive Officer & Director
Fernando Araujo Chief Financial Officer & Treasurer
Gerardo Hernandez Chief Financial Officer & Treasurer
Anil Ranganath Advisor
Matthew Forsyth Senior Vice President, General Counsel & Corporate Secretary
Miriam C. Provost Vice President of Global Regulatory Affairs
Nicholas Corcoran Senior Vice President of Supply Chain & Operations
Tamer I. Khayal Senior Vice President of International

Latest SEC Filings

Date Type Title
Oct 30, 2026 4 Filing
Sep 29, 2026 3 Filing
Sep 14, 2026 4 Filing
Sep 10, 2026 8-K Current Report
Aug 17, 2026 4 Filing
Aug 04, 2026 10-Q Quarterly Report
Aug 04, 2026 8-K Current Report
Jul 14, 2026 4 Filing
Jul 14, 2026 4 Filing
Jul 14, 2026 4 Filing
View All SEC Filings ➞
TransMedics
TransMedics logo
Country United States
IPO Date May 2, 2019
Industry Medical - Devices
Sector Healthcare
Employees 898
CEO Waleed H. Hassanein

Contact Details

200 Minuteman Road Andover, Massachusetts 01810 United States

Stock Details

Ticker Symbol TMDX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001756262
CUSIP Number 89377M109
ISIN Number US89377M1099
SIC Code 3845

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.